1. McGuffin P, Asherson P, Owen M, Farmer A. The strength of the genetic effect. Is there room for an environmental influence in the aetiology of schizophrenia? Br J Psychiatry 1994;164:593-599.
2. Bachmann RF, Schloesser RJ, Gould TD, Manji HK. Mood stabilizers target cellular plasticity and resilience cascades: implications for the development of novel therapeutics. Mol Neurobiol 2005;32:173-202.
3. Bartels SJ, Clark RE, Peacock WJ, Dums AR, Pratt SI. Medicare and medicaid costs for schizophrenia patients by age cohort compared with costsfor depression, dementia, and medically ill patients. Am J Geriatr Psychiatry 2003;11:648-657.
4. Bauer M, Unutzer J, Pincus HA, Lawson WB, NIMH Affective Disorders Workgroup. Bipolar disorder. Ment Health Serv Res 2002;4:225-229.
5. Shih RA, Belmonte PL, Zandi PP. A review of the evidence from family, twin and adoption studies for a genetic contribution to adult psychiatric disorders. Int Rev Psychiatry 2004;16:260-283.
6. Sanders AR, Duan J, Levinson DF, Shi J, He D, Hou C, et al. No significant association of 14 candidate genes with schizophrenia in a large European ancestry sample: implications for psychiatric genetics. Am J Psychiatry 2008;165:497-506.
8. Miki Y, Swensen J, Shattuck-Eidens D, Futreal PA, Harshman K, Tavtigian S, et al. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 1994;266:66-71.
9. MacKinnon DF, Xu J, McMahon FJ, Simpson SG, Stine OC, McInnis MG, et al. Bipolar disorder and panic disorder in families: an analysis of chromosome 18 data. Am J Psychiatry 1998;155:829-831.
10. McMahon FJ, Simpson SG, McInnis MG, Badner JA, MacKinnon DF, DePaulo JR, et al. Linkage of bipolar disorder to chromosome 18q and the validity of bipolar II disorder. Arch Gen Psychiatry 2001;58:1025-1031.
11. Potash JB, Zandi PP, Willour VL, Lan TH, Huo Y, Avramopoulos D, et al. Suggestive linkage to chromosomal regions 13q31 and 22q12 in families with psychotic bipolar disorder. Am J Psychiatry 2003;160:680-686.
13. Willour VL, Zandi PP, Badner JA, Steele J, Miao K, Lopez V, et al. Attempted suicide in bipolar disorder pedigrees: evidence for linkage to 2p12. Biol Psychiatry 2007;61:725-727.
14. Raybould R, Green EK, MacGregor S, Gordon-Smith K, Heron J, Hyde S, et al. Bipolar disorder and polymorphisms in the dysbindin gene (DTNBP1). Biol Psychiatry 2005;57:696-701.
15. Schulze TG, McMahon FJ. Defining the phenotype in human genetic studies: forward genetics and reverse phenotyping. Hum Hered 2004;58:131-138.
17. Carter JW, Parnas J, Cannon TD, Schulsinger F, Mednick SA. MMPI variables predictive of schizophrenia in the Copenhagen high-risk project: a 25-year follow-up. Acta Psychiatr Scand 1999;99:432-440.
18. Claridge G, Beech T. Fully and Quasi-Dimensional Constructions of Schizotypy. In: Raine A, Lencz T, Mednick SA, editor. Schizotypal Personality. Cambridge University Press, New York: 1995, p. 192-216.
19. Matsui M, Gur RC, Turetsky BI, Yan M, Gur RE. The relation between tendency for psychopathology and reduced frontal brain volume in healthy people. Neuropsychiatry Neuropsychol Behav Neurol 2000;13:155-162.
20. Haier RJ, Murphy DL, Buchsbaum MS. Paranoia and platelet MAO in normals and nonschizophrenic psychiatric groups. Am J Psychiatry 1979;136:308-310.
21. Haier RJ, Buchsbaum MS, Murphy DL, Gottesman II, Coursey RD. Psychiatric vulnerability, monoamine oxidase, and the average evoked potential. Arch Gen Psychiatry 1980;37:340-345.
22. Ogura C, Hirano K, Nageishi Y, Takeshita S, Fukao K, Hokama H, et al. Deviate P200 and P300 in non-patient college students with high scores on the schizophrenia scale of the Minnesota Multiphasic Personality Inventory (MMPI). Int J Psychophysiol 1994;16:89-97.
23. Haier RJ, Rieder RO, Khouri PJ, Buchsbaum MS. Extreme MMPI scores and the Research Diagnostic Criteria. Screening college men for psychopathology. Arch Gen Psychiatry 1979;36:528-534.
24. Lenzenweger MF. Confirming schizotypic personality configurations in hypothetically psychosis-prone university students. Psychiatry Res 1991;37:81-96.
25. Merritt RD, Balogh DW, DeVinney SE. Use of the MMPI to assess the construct validity of the revised social anhedonia scale as an index of schizotypy. J Pers Assess 1993;60:227-238.
26. Moldin SO, Gottesman II, Erlenmeyer-Kimling L. Psychometric validation of psychiatric diagnoses in the New York High-Risk study. Psychiatry Res 1987;22:159-177.
28. Chapman LJ, Chapman JP, Raulin ML. Scales for physical and social anhedonia. J Abnorm Psychol 1976;85:374-382.
29. Greene RL. The MMPI-2/MMPI. An Interpretive Manual. Boston: Allyn & Bacon; 1991.
30. Kim YH, Kim JH, Kim JS, Noh MR, Shin DG, Yeum TH, et al. The Main Principles for Minnesota Multiphasic Personality Inventory (MMPI). Seoul: Korea Guidance; 1989.
31. Nurnberger JI Jr, Blehar MC, Kaufmann CA, York-Cooler C, Simpson SG, Harkavy-Friedman J, et al. Diagnostic interview for genetic studies. Rationale, unique features, and training. NIMH Genetics Initiative. Arch Gen Psychiatry 1994;51:849-859. discussion 863-864.
32. Maxwell ME. Family Interview for Genetic Studies (FIGS): Manual For FIGS. (Clinical Neurogenetics Branch, Intramural Research Program). Bethesda, MD: National Institute of Mental Health; 1992.
33. Walss-Bass C, Escamilla MA, Raventos H, Montero AP, Armas R, Dassori A, et al. Evidence of genetic overlap of schizophrenia and bipolar disorder: linkage disequilibrium analysis of chromosome 18 in the Costa Rican population. Am J Med Genet B Neuropsychiatri Genet 2005;139B:54-60.
35. Green RL. Introduction. In: Green RL, editor. The MMPI: Use with Specific Populations. Philadelphia, PA: Grune and Stratton, 1988, p. 1-21.
36. Matsui M, Sumiyoshi T, Niu L, Kurokawa K, Kurachi M. Minnesota Multiphasic Personality Inventory profile characteristics of schizotypal personality disorder. Psychiatry Clin Neurosci 2002;56:442-452.
37. Walters GD. Schizophreia. In: Green RL, editor. The MMPI: Use with Specific Populations. Philadelphia, PA: Grune and Stratton, 1988, p. 50-73.
38. Moldin SO, Gottesman II, Erlenmeyer-Kimiling L. Psychometric validation of psychiatric diagnosis in the New York high-risk study. Psychiatry Res 1987;22:159-177.
40. Meehl PE. Schizotaxia, schizotypy, and schizophrenia. Am Psychol 1962;17:827-838.
41. Gilberstadt H, Duker J. A Handbook of Clinical and Actuarial MMPI Interpretation. Philadelphia: W.B. Saunders Company; 1965.
43. Marks PA, Seeman W, Haller DH. The Actuarial Use of the MMPI With Adolescents and Adults. Baltimore: The Williams & Wilkins Company; 1974.
48. Schulman SM. Cognitive deficit in students identified by the elevated 2-7-8 code of the MMPI. Diss Abstr Int 1976;37:3096B
49. Dahlstrom WG, Welsh GS, Dahlstrom LE. An MMPI Handbook: Vol. II. Research Applications. Minneapolis: University of Minnesota Press; 1975.
50. Sim M, Kim JH, Yim SJ, Cho SJ, Kim SJ. Increase in harm avoidance by genetic loading of schizophrenia. Compr Psychiatry 2012;53:372-378.
52. Yoneyama E, Matsui M, Kawasaki Y, Nohara S, Takahashi T, Hagino H, et al. Gray matter features of schizotypal disorder patients exhibiting the schizophrenia-related code types of the Minnesota Multiphasic Personality Inventory. Acta Psychiatr Scand 2003;108:333-340.